Conavi Medical Corp.
CNVIF
Rang in aandelen
#33304
Conavi Medical Corp. is a medical technology firm that specializes in... Conavi Medical Corp. is a medical technology firm that specializes in developing, manufacturing, and commercializing advanced imaging solutions. These innovations are specifically designed to provide guidance during minimally invasive cardiovascular procedures. A notable product is the Novasight Hybrid System, which uniquely combines intravascular ultrasound (IVUS) and optical coherence tomography (OCT) into a single platform. This enables clinicians to obtain simultaneous and precisely co-registered images of the coronary arteries. Conavi Medical Corp. is headquartered in Toronto, Canada.
Aandeelprijs
$0.088
Marktkapitalisatie
$7.51M
Verandering (1 dag)
-11.65%
Verandering (1 jaar)
-89.24%
Land
CA
Handel Conavi Medical Corp. (CNVIF)
Categorie
Healthcare
P/S-ratio voor Conavi Medical Corp. (CNVIF)
P/S-ratio op October 2026 TTM: 0.77
Volgens de meest recente financiële rapporten en aandelenkoers van Conavi Medical Corp. is de huidige P/S-ratio (TTM) 0.77. Eind 2022 had het bedrijf een P/S-ratio van 0.00.
P/S-ratiohistoriek voor Conavi Medical Corp. van 2007 tot 2026
P/S-ratio aan het einde van elk jaar
| Jaar | P/S-ratio | Wijzigen |
|---|---|---|
| 2026 (TTM) | 0.77 | -91.99% |
| 2023 | 9.67 | 0.00% |
| 2022 | 0.00 | -100.00% |
| 2021 | 85.60 | -39.99% |
| 2020 | 142.65 | 0.00% |
| 2019 | 0.00 | 0.00% |
| 2018 | 0.00 | 0.00% |
| 2017 | 0.00 | 0.00% |
| 2016 | 0.00 | 0.00% |
| 2015 | 0.00 | 0.00% |
| 2014 | 0.00 | 0.00% |
| 2013 | 0.00 | 0.00% |
| 2012 | 0.00 | 0.00% |
| 2011 | 0.00 | 0.00% |
| 2010 | 0.00 | 0.00% |
| 2009 | 0.00 | 0.00% |
| 2008 | 0.00 | 0.00% |
| 2007 | 0.00 | 0.00% |
P/S-ratio voor vergelijkbare bedrijven of concurrenten
| Bedrijf | P/S-ratio | Verschil in P/S-ratio | Land |
|---|---|---|---|
| 3.82 | 393.65% |
US
|
|
| 2.78 | 259.43% |
IE
|
|
| 4.18 | 439.33% |
US
|
|
| 2.97 | 283.38% |
US
|
|
| - | - |
DE
|
